Scientists Take Another Step Toward Creating an HIV Vaccine

Article

The scientific group of Peter the Great St. Petersburg Polytechnic University headed by professor Andrei Kozlov published the results of a study devoted to the search of solutions for creating the HIV vaccine.

During two years, with the support of the Russian Science Foundation's grant, researchers studied features of transmitted variants of HIV-1 virus. This type of HIV transmission is most typical for Russian Federation.

Within the framework of the project, scientists have studied blood samples of injecting drug users with acute or early stages of HIV infection. The transmission of only one viral variant was detected in 70 percent of cases. These data were obtained by the method of single genome analysis (SGA), which allows to analyze 20-30 single genomes. In addition, the scientific group used the next-generation sequencing approach (NGS), capable of analyzing up to 5000 genomes. Thus, scientists managed to establish that all viruses are the "descendants" of any one virus particle. This phenomenon is called the genetic bottleneck effect. The research results are described in the article "Characterization of the Transmitted Virus in an Ongoing HIV-1 Epidemic Driven by Injecting Drug Use" published in the journal AIDS Research and Human Retroviruses.

"Though this work is fundamental, we are working with the genes of the viruses, which can be used in design of vaccine against HIV. So to speak, it is necessary to create the vaccine not against all possible viruses, but against those which are transmitted and cause the infection. We will use these data in the further work on HIV vaccine development," notes Kozlov.

Source: Peter the Great St. Petersburg Polytechnic University

Recent Videos
Pathogen Playbook Presenter: Sharon Ward-Fore, BS, MS, MT(ASCP), CIC, FAPIC
Mark Wiencek, PhD
Rebecca Crapanzano-Sigafoos, DrPH, CIC, AL-CIP, FAPIC
The CDC’s updated hospital respiratory reporting requirement has added new layers of responsibility for infection preventionists. Karen Jones, MPH, RN, CIC, FAPIC, clinical program manager at Wolters Kluwer, breaks down what it means and how IPs can adapt.
Studying for the CIC using a digital tablet and computer (Adobe Stock 335828989 by NIKCOA)
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Cheron Rojo, BS, FCS, CHL,  CER, CFER, CRCST
Matthias Tschoerner, Dr Sc
Standardizing Cleaning and Disinfection
Related Content